Avista, Nordic Ink $439M Deal To Acquire Swiss Drugmaker

Law360, Washington (October 2, 2013, 1:18 PM EDT) -- Private equity firms Avista Capital Partners and Nordic Capital have agreed to purchase the Swiss drugmaker Acino Holding AG in a $439 million deal, Acino announced Wednesday.

Under the terms of the deal, Avista's and Nordic's subsidiary Pharma Strategy Partners GmbH will purchase all outstanding Acino shares for 115 Swiss francs (US$127.66) per share, a 33 percent markup on Tuesday's closing share price. Following completion of the tender offer, Acino will be delisted from the SIX Swiss Exchange, the company said.

Acino's board of directors praised...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.